Sykes M - Search Results

1

Dissociating graft-vs-host disease from the graft-vs-leukemia effect of allogeneic T cells: the potential role of IL-2.

Sykes M. Sykes M. Bone Marrow Transplant. 1992;10 Suppl 1:1-4. Bone Marrow Transplant. 1992. PMID: 1521080 Review. No abstract available.

2

Mixed allogeneic chimeras prepared by a non-myeloablative regimen: requirement for chimerism to maintain tolerance.

Sharabi Y, Abraham VS, Sykes M, Sachs DH. Sharabi Y, et al. Among authors: sykes m. Bone Marrow Transplant. 1992 Mar;9(3):191-7. Bone Marrow Transplant. 1992. PMID: 1387333

3

Alloengraftment in IL-2-treated mice.

Sykes M, Pearson DA. Sykes M, et al. Bone Marrow Transplant. 1992 Aug;10(2):157-63. Bone Marrow Transplant. 1992. PMID: 1525605

4

The mechanism of IL-2-mediated protection against GVHD in mice. II. Protection occurs independently of NK/LAK cells.

Sykes M, Abraham VS. Sykes M, et al. Transplantation. 1992 May;53(5):1063-70. doi: 10.1097/00007890-199205000-00018. Transplantation. 1992. PMID: 1533968

5

Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4-CD8- cell population.

Abraham VS, Sachs DH, Sykes M. Abraham VS, et al. Among authors: sykes m. J Immunol. 1992 Jun 15;148(12):3746-52. J Immunol. 1992. PMID: 1534824

6

Effect of natural antibody on xenogeneic bone marrow engraftment.

Sykes M, Sachs DH, Aksentijevich I. Sykes M, et al. Transplant Proc. 1992 Apr;24(2):497-8. Transplant Proc. 1992. PMID: 1566403 No abstract available.

7

Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.

Aksentijevich I, Sachs DH, Sykes M. Aksentijevich I, et al. Among authors: sykes m. Transplantation. 1992 May;53(5):1108-14. doi: 10.1097/00007890-199205000-00025. Transplantation. 1992. PMID: 1585475

8

Mechanism of the anti-GVHD effect of IL-2. I. Protective host-type cell populations are not induced by IL-2 treatment alone.

Abraham VS, Sykes M. Abraham VS, et al. Among authors: sykes m. Bone Marrow Transplant. 1991;7 Suppl 1:29-32. Bone Marrow Transplant. 1991. PMID: 2043882

9

In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.

Sykes M, Romick ML, Hoyles KA, Sachs DH. Sykes M, et al. J Exp Med. 1990 Mar 1;171(3):645-58. doi: 10.1084/jem.171.3.645. J Exp Med. 1990. PMID: 2307931 Free PMC article.

10

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.

Sykes M, Romick ML, Sachs DH. Sykes M, et al. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5633-7. doi: 10.1073/pnas.87.15.5633. Proc Natl Acad Sci U S A. 1990. PMID: 2377601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

928 results

Search Page

Filters